Brielle Reyes
Gerontology · Cary, NCNPI 1811502669
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,162 of the $4,415 with a category attached, or 71.6%. 22 manufacturers reported payments, led by Boston Scientific at 52.4% of the total. Reporting peaked in 2024 at $2,871 and has fallen 85.2% since, to $426 in 2025. Among gerontology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 111 payments — averaging $39.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Esperion Therapeutics, Inc.$241
- Boehringer Ingelheim$240
- Medtronic$220
- Irhythm Technologies, Inc.$188
- Novartis$179
- plus $1K from 16 others
What the payments were for
- Travel & lodging$1,25228%
- Food & beverage$3,16272%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 17 | $2,313 |
| Esperion Therapeutics, Inc. | 9 | $241 |
| Boehringer Ingelheim | 8 | $240 |
| Medtronic | 5 | $220 |
| Irhythm Technologies, Inc. | 6 | $188 |
| Novartis | 11 | $179 |
| AstraZeneca | 9 | $177 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 13 | $115 |
| Biosense Webster, Inc. | 1 | $114 |
| Amgen | 5 | $101 |
| Merck | 5 | $76 |
| Novo Nordisk | 4 | $71 |
| Sanofi-aventis U.S. LLC | 3 | $66 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $57 |
| Pfizer | 3 | $50 |
| Alnylam Pharmaceuticals Inc. | 2 | $44 |
| Edwards Lifesciences | 2 | $40 |
| Kestra Medical Technology Services, Inc. | 2 | $35 |
| Sanofi | 1 | $28 |
| E.r. Squibb & Sons, L.L.C. | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Johnson & Johnson | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WATCHMAN Access System$1,433
- WATCHMAN FLX$429
- LUX-Dx Insertable Cardiac Monitor$119
- NEXLIZET$115
- NEXLETOL$115
- Carto 3$114
- QDOT MICRO Catheter$114
- Micra$102
How this compares
$4,415 in reported general payments places this provider in the 95th percentile of 165 gerontology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 218 | $198,541 |
| EntrestoSacubitril/Valsartan | 104 | $88,715 |
| JardianceEmpagliflozin | 54 | $50,884 |
| FarxigaDapagliflozin Propanediol | 47 | $33,139 |
| XareltoRivaroxaban | 28 | $27,111 |
| BrilintaTicagrelor | 19 | $13,969 |
| Metoprolol Succinate | 265 | $4,380 |
| Valsartan | 78 | $2,622 |
| Ranolazine ErRanolazine | 26 | $2,545 |
| Nebivolol Hcl | 19 | $1,429 |
| Atorvastatin Calcium | 115 | $1,425 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 47 | $1,375 |
| Rosuvastatin Calcium | 76 | $945 |
| Losartan Potassium | 75 | $878 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 75 | $869 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $50 | $198,541218 claims |
| NovartisEntresto | $179 | $88,715104 claims |
| Boehringer IngelheimJardiance | $240 | $50,88454 claims |
| AstraZenecaFarxiga, Brilinta | $177 | $47,10866 claims |
| Johnson & JohnsonXarelto | $17 | $27,11128 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 165 gerontology providers in North Carolina.
Other gerontology in Cary
- Kayo NakamaCary$1K
- Sharon BibyGreensboro$22K
- Lora StephensStatesville$12K
- Kimberly SmithRaleigh$10K
- Michelle WoodCharlotte$9K
- Corinne NantzFuquay Varina$5K
- Taskeen MidgetteNew Bern$5K
- Karen PattersonSouthern Pines$4K
- Morgan MillerRocky Mount$4K
- Chelsea CarlanReidsville$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.